CI

At a glance

ClinicalIndex Comparison Record
N/ANot Yet Recruiting· 30 target
Drug / intervention
Origin Satiety Complex +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07390266
NCT07390266N/ANot Yet Recruiting

A Randomized, Triple-blind, Placebo-controlled, Cross-over Clinical Trial to Determine the Safety and Efficacy of an Origin Satiety Complex on Self-reported Hunger and Satiety in Healthy Adults

Vora Life LLC·interventional·Posted Feb 5, 2026·Updated Feb 5, 2026

In Brief

A clinical study evaluating Origin Satiety Complex and Placebo for High BMI and 3 related conditions. Not yet recruiting, targeting 30 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to the safety and efficacy of the investigational product (IP), Origin Satiety Complex, on hunger and satiety in healthy adults. The main question it aims to answer is what is the difference in the net incremental area under the curve (niAUC) for self-reported postprandial hunger and satiety (T = 0 - T = 10.5 h), as assessed by satiety and hunger items of the Eating Behavior Visual Analog Scales (VAS), between the IP and placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ANot Yet RecruitingOverdue
2026
First PostedFeb 5, 2026
Enrollment StartMar 1, 2026
Primary CompletionApr 1, 2026
TodayJul 1, 2026
Enrollment to primary: 1 monthPosted 5 months ago

Interventions

Origin Satiety Complexdietary

Participants will be instructed to consume five doses of study product premixed in 10 ounces of water in an opaque container.

Placeboother

Participants will be instructed to consume five doses of study product premixed in 10 ounces of water in an opaque container.